Module

Inhibitors of Human Immunodeficiency Virus Type I Integration

Source: HIV/AIDS Annual Update 2007

Inhibitors of Human Immunodeficiency Virus Type I Integration

Faculty:
Daria J. Hazuda, PhD

CME CREDIT INFORMATION

Release Date: 07/13/07

Expiration Date: 07/12/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.1 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the role of integrase in HIV-1 replication
Identify the mechanism of integrase inhibitors and how inhibitors may lead to resistant mutations
Discuss the future potential of integrase inhibitors

Topics covered include:

Introduction
Overview of the Role of Integrase in HIV-1 Replication
Integrase Inhibitors: Structure and Function
Integrase Strand Transfer Inhibitors
Conclusions
Summary: Implications for Clinical Practice
References

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.